Vascular Biogenics OverviewVascular Biogenics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for VBLT.
Quarterly EBIT
-$5.38M
↓ 723.41% YoY
As of Jun 30, 2024
Annual EBIT (TTM)
-$64.14M
↓ 67% YoY
Trailing 12 months ending Jun 30, 2024
Vascular Biogenics OverviewEBIT (Earnings Before Interest and Taxes) analysis for VBLT.
As of Jun 30, 2024
Trailing 12 months ending Jun 30, 2024